Clinical experience with 2'-deoxycoformycin

Hematology and Cell Therapy

Volumn 38, Issue SUPPL. 2, 1996, Pages

  Catovsky, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

CAMPATH 1H; DCF; hairy cell leukemia; Sezary syndrome; T prolymphocytic leukemia

Indexed keywords

PENTOSTATIN;

CLINICAL TRIAL; HAIRY CELL LEUKEMIA; HUMAN; PHASE 2 CLINICAL TRIAL; SHORT SURVEY; T CELL LEUKEMIA; T CELL LYMPHOMA;

ANTIBIOTICS, ANTINEOPLASTIC; CLINICAL TRIALS, PHASE II; HUMANS; LEUKEMIA, HAIRY CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; PENTOSTATIN; SEZARY SYNDROME;

EID: 0029823434     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (25)

1. Brito-Babapulle V, Catovsky D (1991) Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet 55 : 1-9
2. Brito-Babapulle F, Huang D, Lavender P, Galton D, Catovsky D (1988) Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deoxycoformycin. Eur J Haematol 40 : 185-187
3. Catovsky D, Matutes E, Talavera JG, O'Connor NTJ, Johnson SAN, Emmett E, Corbett L, Swansbury J (1994) Long term results with 2′deoxycoformycin in hairy cell leukemia. Leukemia Lym phoma 14 (Suppl 1] : 109-113
4. Dearden C, Catovsky D (1990) Deoxycoformycin in the treatment of mature B-cell malignancies. Br J Cancer 62 : 4-5
5. Dearden C, Catovsky D (1990) Treatment of hairy cell leukemia with 2′-deoxycoformycin. Leukemia Lymphoma 1 : 179-185
6. Dearden C, Matutes E, Catovsky D (1991) Deoxycoformycin in the treatment of mature T-cell leukaemias. Br J Cancer 64 : 903-906
7. Dearden CE, Matutes E, Hoffbrand AV, Ganeshaguru K, Brozovic M, Williams HJH, Traub N, Mills M, Linch DC, Catovsky D (1987) Membrane phenotype and response to deoxycoformycin in mature T cell malignancies. Br Med J 295 : 873-875
8. Diamandidou E, Cohen PR, Kurzrock R (1996) Mycosis fungoides and Sezary syndrome. Blood 88 : 2385-2409
9. Grever M, Kopecky K, Foucar MK, Head D, Bennett JM, Hutchin son RE, Corbett WEN, Cassileth PA, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson BD (1995) Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol 13 : 974-982
10. Grever MR, Siaw MFE, Jacob WF, Neidhart JA, Miser JS, Coleman MS, Hutton JJ, Balcerzak SP (1981) The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoprolifera tive malignancy. Blood 57 : 406-417
11. Habermann TM, Anderson JW, Cassileth PA, Bennett JM, Oken MM (1992) Sequential administration of recombinant Interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia. Br J Haematol 80 : 466-471
12. Johnson S, Catovsky D, Child J, Newland AC, Milligan D, Jan mohamed R (1996) Phase I/II evaluation of 2′deoxycoformycin (Pentostatin) in a five-day schedule for the treatment of relapsed/refractory chronic lymphocytic leukaemia (CLL) (abstract). ASH meeting, December 1996. Blood 88 : to be published
13. Kraut EH, Grever MR, Bouroncle BA (1994) Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood 84 : 4061-4063
14. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D (1991) Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78 : 3269-3274
15. Mercieca J, Matutes E, Dearden C, MacLennan K, Catovsky D (1994) The role of pentostatin in the treatment of T-cell malig nancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol 12 : 2588-2593
16. Mercieca J, Matutes E, Emmett E, Coles H, Catovsky D (1996) 2-chlorodeoxyadenosine in the treatment of hairy cell leukaemia: differences in response in patients with and without abdominal lymphadenopathy. Br J Haematol 93 : 409-411
17. Mercieca J, Matutes E, Moskovic E, MacLennan K, Matthey F, Costello C, Behrens J, Basu S, Roath S, Fairhead S, Flandrin G, Brizard A, Catovsky D (1992) Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases. Br J Haematol 82 : 547-554
18. Pawson R, Dyer MJS, Barge R, Matutes E, Thornton PD, Emmett E, Kluin-Nelemans JC, Fibbe WE, Willemze R, Catovsky D (1996) Successful treatment of T-cell prolymphocytic leukaemia with human CDw52 antibody, CAMPATH-1H (Submitted for publication)
19. Piro LD, Carrera CJ, Carson DA, Beutler E (1990) Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322 : 1117-1121
20. Prentice HG, Russell NH, Lee N, Ganeshaguru K, Blacklock H, Piga A, Smyth JF, Hofffbrand AV (1981) Therapeutic selectivity of and prediction of response to 2′-deoxycoformycin in acute leukaemia. Lancet 2 : 1250-1254
21. Sainati L, Matutes E, Mulligan SP, de Oliveira MP, Rani S, Lampert IA, Catovsky D (1990) A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. Blood 76 : 157-162
22. Spiers ASD, Moore D, Cassileth PA, Harrington DP, Cummings JF, Neiman RS, Bennett JM, O'Connell MJ (1987) Remissions in hairy cell leukemia with pentostatin (2′-deoxycoformycin). N Engl J Med 316: 825-830
23. Spiers ASD, Parekh SJ, Bishop MB (1984) Hairy cell leukaemia: induction of complete remission with pentostatin (2′- deoxycoformycin). J Clin Oncol 2 : 1336-1342
24. Tallman MS, Hakimian D, Rademaker AW, Zanzig C, Wollins E, Rose E, Peterson LC (1996) Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood 88 : 1954-1959
25. Yuille MAR, Abraham SV, Coignet LJA, Lakin ND, Yaqub F, Matutes E, Brito-Babapulle V, Jackson SP, Dyer MJS, Catovsky D (1996) Abnormalities of the ataxia telangiectasia gene (ATM) in T-prolymphocytic leukemia (abstract). ASH Meeting, December 1996. Blood 88 : to be published